+852 54195003
Can Oral Strips Replace Tablets In Supplement Portfolios?
Brand owners keep asking suppliers to move low-dose nutrients out of pills and into strips. Two 2026 forecasts show the format is now large enough to plan around, even if it never displaces compressed units.
Near Ten Percent Growth Compounds Annually
Mordor Intelligence values the oral thin films market at USD 3.61 billion in 2026 and forecasts USD 5.64 billion by 2031, a 9.35% compound annual rate. Coherent Market Insights, working a wider 2026 to 2033 window, sizes the same market at USD 3.73 billion rising to USD 7.18 billion at 9.8%. Those base estimates sit within 3% of each other, so procurement teams can treat the near ten percent trajectory as a planning constant rather than one analyst’s optimism.
Sublingual Deliveries Hold Above Half
Sublingual film captured 54.72% of 2025 revenue in Mordor’s product segmentation and 56.6% in Coherent’s, because placement beneath the tongue bypasses first-pass Metabolism and shortens onset time. Buccal strips are the quicker-growing slice at 11.12% compound growth, a detail worth noting for brands weighing film placement options.
Loading Limits Decide Which Actives Fit
Mordor pegs film loading near 30% active by weight, which caps commercial strips around 30 mg. That ceiling quietly writes the product roadmap: Melatonin, vitamin B12 and D3 with K2 fit comfortably, while bulky botanical doses belong in tablets or capsule formats. Buyers scouting a private label oral dissolving film should match dose to film area before approving artwork.
Online Pharmacies Outpace Counter Sales
Retail pharmacies still held 48.10% of 2025 revenue, yet online channels are forecast to compound at 12.08% through 2031 as telehealth refills and temperature-controlled mailers mature. Brands built for marketplace and direct storefronts therefore extract more from the format than pharmacy-only ranges.
Asia Pacific Adds Capacity Fastest
Asia Pacific is the fastest-growing region at 10.12% compound growth, set against North America’s 41.20% share of global value. Mordor attributes the momentum to solvent-casting capacity in China and India, which shortens sampling cycles for overseas buyers.
One Factory Covers Several Formats
Geerlun runs film, softgels, gummies and hard capsules under a single quality system, so a brand can pilot strips beside existing lines without opening a second supplier file. Send a dose and target market to compare specifications against your current format.